Recalled Products
A. AOR Nattokinase (Ultra)
As a result of a trade complaint, the HPFB Inspectorate requested a Health Hazard Evaluation of these products. NHPD's HHE responses classified both products as a Type II Health Hazard due to the label indication that the product supports fibrinolysis, the breaking up of thrombi by reducing excessive levels of plasminogen activator inhibitor type 1, which implies that it may be used to treat embolic or thrombotic disorders and indicates that it may interact with other prescription or non-prescription fibrinolytic or blood-thinning drugs.